Furthermore, the presence of tau seeding, which can lead to AD pathology [37,98,100,102,105,174,175,176], has been observed in the brains of patients with MS [177], and tau also may contribute to impaired oligodendrocyte maturation and pathological changes that may foster demyelination [178]. This evidence concerns the gene MAPT and myeloid sarcoma.